ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol.45, no.10, pp.1303-1318, 2017 (SCI-Expanded)
Article / Review
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Hacettepe University Affiliated:
BackgroundIron deficiency anaemia (IDA) is a common complication of inflammatory bowel disease (IBD) associated with reduced quality of life and increased hospitalisation rates. While the best way of treating IDA in IBD patients is not clearly established, current European guidelines recommend intravenous iron therapy in IBD patients with severe anaemia or intolerance to oral iron compounds.